The $2.3 billion awarded to St. Jude Medical Inc. (NYSE:STJ) by a jury over a trade secret theft trial was pared back by the judge overseeing the case, leaving St. Jude with just under $1 billion and a wide-ranging injunction against former employee Yongning Zou.
Zou was accused of using his access to highly confidential information to swipe details on STJ-branded pacemakers, defibrillators and neuromodulators and found Nervicon Co. Ltd. in China.